Giuseppe Aminzade joins Hogan Lovells as head of the Life Sciences regulatory department in Italy

Giuseppe Aminzade, joins us from Rucellai & Raffaelli law firm, where he coordinated a Life Sciences and Health Care regulatory team, dealing with health and pharmaceutical law, contracts, medical and health liability, anti-corruption and administrative liability of companies pursuant to Legislative Decree 231/2001.

According to Christian Di Mauro, Head of the Life Sciences & Health Care practice in Italy: "Our Life Sciences and Health Care team, counting 30 professionals with 11 partners, will be further boosted by Giuseppe’s arrival. The assistance in the regulatory sector has always been a key element of our Clients, leading multinational companies and innovative startups. We successfully help clients in the health and life sciences arenas navigate the challenges of the market, especially in the recent months."

Luca Picone, country managing partner comments "We welcome Giuseppe to Hogan Lovells. This new entry is part of a careful growing strategy of the Firm in Italy aimed also to attract outstanding professionals with expertise in sectors in which our clients could better appreciate the added value of the legal service".

Philip Katz, who leads the firm’s Pharmaceuticals & Biotechnology regulatory practice, said that "Giuseppe further strengthens our ability to serve our clients globally. He brings together deep knowledge of regulatory law and nuanced understanding of our clients’ businesses to craft creative and practical solutions, which is what we do best."

Giuseppe will coordinate the Life Sciences and Health Care regulatory team in Italy, adding a new and valuable contribution to the international team, led by Steve Abrams, Lynn Mehler and Jane Summerfield. Giuseppe will also advise our clients after many years of experience as consultant and President of Supervisory Bodies pursuant to Legislative Decree 231/01 of leading national and multinational companies.